“ Patience is bitter, but its fruit is sweet.....”
@Jov88 Holy moly, seriously Im having goose bumps. “BitterSweet” was exactly my 2 words intended reply to @Zuzi01.
Had a taste of experience when I was only a junior manager during several M&A and takeovers, including the L@MH, B@@D Brewing China. The worse part was “bureaucracy from both the government agencies and/or company politics”, which I’m fully confident Imugene has the most stellar management team in place to handle them, should they ever arise . But end of the day, we are an Aussie company whose 4 game changing drugs the whole world would dream to be part of it. And, of course, our needy patients in particular!
Good luck all. Meanwhile, let the SCIENCE do the talking/dancing. Everything else will follow !
If I have the magic wand, I love to dream our value to reach $33b one day in the future. 33 comes from our CF33 ov. Why not, it’s only $8b per each of the 4 potential paradigm shifting drugs. The $value issue becomes “irrelevant “ if you can CURE and SAVE lives ? Don’t you think so
dyor
IMU Price at posting:
17.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)